Montaniel et al. used a mouse model of maternal high-fat diet-induced obesity and sitagliptin to assess whether it can inhibit DPP-4 activity in vivo and, thus, block fetal programming toward obesity. This evidence concerns the gene DPP4 and obesity due to melanocortin 4 receptor deficiency.